Acne Vulgaris Treatment Market Competitive Analysis, Regional Outlook and Forecast Analysis during 2022-2028

 

Acne Vulgaris Treatment Market

Blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest are the main features of the common skin condition acne vulgaris. Although frequently seen in adolescents, it can also affect adults. Acne can be divided into three categories: mild, moderate, and severe. Sebaceous glands under the skin produce too much oil, which causes them to clog and swell. Acne can also affect female patients with polycystic ovarian syndrome and even hormonal issues like excessive androgen production. Social withdrawal, low self-esteem, and depression with suicidal thoughts are common in people with acne vulgaris.

Over the forecast period, the U.S. is anticipated to be the Global Acne Vulgaris Treatment Market with the highest volume of acne vulgaris treatment products. A 2015 study that was published in the British Journal of Dermatology estimated that 9.4% of the world's population suffered from acne. Additionally, acne is the eighth most common disease in the world. The biggest market for treatments for acne vulgaris is the United States. Over $3 billion was spent on treating acne vulgaris in the United States in 2013, according to a study by the National Institutes of Health (NIH). According to the American Academy of Dermatology, the number of acne vulgaris patients aged 25 and older, particularly women, is significantly increasing in 2014. Furthermore, low awareness regarding the factors causing acne is another factor leading to increasing prevalence acne vulgaris.

Acne Vulgaris Treatment Market Product types-

·        Medications

o   Benzoyl peroxides

o   Retinoids

o   Systemic and topical Antibiotics

o   Hormonal Agents

o   Others (Salicylic Acid, Azelic, Dapsone, and Alternative therapy)

·        Devices

·        Laser devices

·        Heat extraction devices

By 2020, India is anticipated to have the largest population in the 15–25 year age group. As a result, the market for acne vulgaris treatment products is extremely lucrative. Additionally, India has a high glycemic index diet, which is anticipated to help the market grow over the course of the forecast period. Manufacturers are also concentrating on creating products to treat acne-related scarring. Scarring is being treated with new surgical and cosmetic methods, such as laser, chemical peels, and photodynamic therapy. Another factor anticipated to support the growth of the acne vulgaris treatment market is rising consumer preference for alternative methods of treating acne vulgaris, such as herbal therapy (tee tree oil), due to their lack of side effects.

Over the forecast period, home-based acne treatment equipment like Neutrogena and Revive light therapy will see significant growth. In order to improve their product offerings and maintain their market share, major players in the acne vulgaris treatment market are concentrating on partnering, acquiring, and developing new products. For instance, the global beauty company L'Oréal signed a contract with Valeant Pharmaceuticals International, Inc. in 2017 to purchase its portfolio of skin care brands, which included the anti-acne brand AcneFree, for US$1.3 billion. Additionally, Novan Inc. announced in November 2017 that it would carry out a phase three clinical trial for a new anti-acne molecule.

Nitrici, a proprietary nitric oxide technology from Novan, enables the controlled release of nitric oxide from chemical entities. This is advantageous because nitric oxide naturally has the power to regenerate tissue, eliminate invasive microorganisms, prevent clotting, control inflammation, and even help eliminate cancer cells. A further agreement to sell its Obagi Medical Products business for US$ 190 million in cash was signed by Valeant Pharmaceuticals International, Inc. and Haitong International Zhonghua Finance Acquisition Fund I, L.P. in 2017. The market for acne treatment products has a significant presence of Obagi Medical Products.

Major Companies Listed are- Allergan plc, GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.

Comments

Popular posts from this blog

Ginseng Market Outlook, Analysis and forecast up to 2028

Forging has significant application in creation of various metal for wide range of applications

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19